RBC Capital analyst Paul Treiber assigned a Hold rating to BlackBerry (BB – Research Report) today and set a price target of $4.00. The ...

RBC Capital raised the firm’s price target on BlackBerry (BB) to $4 from $3.25 and keeps a Sector Perform rating on the shares after meeting ...

Serna Bio, an AI drug discovery company pioneering RNA-targeting small molecules, today announced the members of its Scientific Advisory Board (SAB). Established in 2021, Serna Bio is a preclinical ...